retatrutide fda approval timeline Status 2026: Everything We Know So Far Retatrutide Hits 30.3% Weight Loss

Digestive Changes: Shifting the dose can sometimes lead to temporary changes in bowel habits, such as mild constipation or diarrhea, as the digestive system adjusts to the new timing

Cmo funciona el epitaln

Clinical trials show average weight loss of 50+ pounds over 3-6 months, with continued gradual loss possible over longer treatment periods

A major concern with GLP-1RAs, despite their potent anti-obesity effects, is post-treatment weight rebound [16]

placebo resulted in significant decreases in total cholesterol, LDL-C, VLDL-C, free fatty acids, and triglycerides and an increase in HDL-C at week 68 of follow up [33]